153P Combination of Tim-3 blockade TQB2618 with PD-1 blockade for patients with immunotherapy-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Preliminary results from a phase II study Article Swipe
Chongyang Xu
,
Yanghong Xia
,
Shi Wang
,
Lili Guo
,
Lin Shen
,
W-H. Hu
,
Pu‐Yun OuYang
,
Xiaojie Fang
,
Min Nie
,
Jun Ma
,
Qiang Cai
·
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.iotech.2024.100782
YOU?
·
· 2024
· Open Access
·
· DOI: https://doi.org/10.1016/j.iotech.2024.100782
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/j.iotech.2024.100782
- OA Status
- gold
- Cited By
- 1
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4405374807
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4405374807Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/j.iotech.2024.100782Digital Object Identifier
- Title
-
153P Combination of Tim-3 blockade TQB2618 with PD-1 blockade for patients with immunotherapy-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Preliminary results from a phase II studyWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2024Year of publication
- Publication date
-
2024-12-01Full publication date if available
- Authors
-
Chongyang Xu, Yanghong Xia, Shi Wang, Lili Guo, Lin Shen, W-H. Hu, Pu‐Yun OuYang, Xiaojie Fang, Min Nie, Jun Ma, Qiang CaiList of authors in order
- Landing page
-
https://doi.org/10.1016/j.iotech.2024.100782Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/j.iotech.2024.100782Direct OA link when available
- Concepts
-
Blockade, Nasopharyngeal carcinoma, Medicine, Immunotherapy, Oncology, Internal medicine, Immune checkpoint, Radiation therapy, Receptor, CancerTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
1Total citation count in OpenAlex
- Citations by year (recent)
-
2025: 1Per-year citation counts (last 5 years)
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4405374807 |
|---|---|
| doi | https://doi.org/10.1016/j.iotech.2024.100782 |
| ids.doi | https://doi.org/10.1016/j.iotech.2024.100782 |
| ids.openalex | https://openalex.org/W4405374807 |
| fwci | 0.53774674 |
| type | article |
| title | 153P Combination of Tim-3 blockade TQB2618 with PD-1 blockade for patients with immunotherapy-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Preliminary results from a phase II study |
| biblio.issue | |
| biblio.volume | 24 |
| biblio.last_page | 100782 |
| biblio.first_page | 100782 |
| topics[0].id | https://openalex.org/T12505 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9983999729156494 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2730 |
| topics[0].subfield.display_name | Oncology |
| topics[0].display_name | Peptidase Inhibition and Analysis |
| topics[1].id | https://openalex.org/T13157 |
| topics[1].field.id | https://openalex.org/fields/13 |
| topics[1].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[1].score | 0.9894999861717224 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1312 |
| topics[1].subfield.display_name | Molecular Biology |
| topics[1].display_name | Cancer-related gene regulation |
| topics[2].id | https://openalex.org/T10417 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9574999809265137 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Lung Cancer Treatments and Mutations |
| is_xpac | False |
| apc_list.value | 2750 |
| apc_list.currency | EUR |
| apc_list.value_usd | 2965 |
| apc_paid.value | 2750 |
| apc_paid.currency | EUR |
| apc_paid.value_usd | 2965 |
| concepts[0].id | https://openalex.org/C2778468042 |
| concepts[0].level | 3 |
| concepts[0].score | 0.8520287275314331 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q273976 |
| concepts[0].display_name | Blockade |
| concepts[1].id | https://openalex.org/C2778997737 |
| concepts[1].level | 3 |
| concepts[1].score | 0.8016366958618164 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1693598 |
| concepts[1].display_name | Nasopharyngeal carcinoma |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.6875714063644409 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2777701055 |
| concepts[3].level | 3 |
| concepts[3].score | 0.6744740009307861 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1427096 |
| concepts[3].display_name | Immunotherapy |
| concepts[4].id | https://openalex.org/C143998085 |
| concepts[4].level | 1 |
| concepts[4].score | 0.4999220371246338 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[4].display_name | Oncology |
| concepts[5].id | https://openalex.org/C126322002 |
| concepts[5].level | 1 |
| concepts[5].score | 0.4956141710281372 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[5].display_name | Internal medicine |
| concepts[6].id | https://openalex.org/C2780851360 |
| concepts[6].level | 4 |
| concepts[6].score | 0.4378805458545685 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q21686041 |
| concepts[6].display_name | Immune checkpoint |
| concepts[7].id | https://openalex.org/C509974204 |
| concepts[7].level | 2 |
| concepts[7].score | 0.1585245132446289 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q180507 |
| concepts[7].display_name | Radiation therapy |
| concepts[8].id | https://openalex.org/C170493617 |
| concepts[8].level | 2 |
| concepts[8].score | 0.14489108324050903 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[8].display_name | Receptor |
| concepts[9].id | https://openalex.org/C121608353 |
| concepts[9].level | 2 |
| concepts[9].score | 0.11241203546524048 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q12078 |
| concepts[9].display_name | Cancer |
| keywords[0].id | https://openalex.org/keywords/blockade |
| keywords[0].score | 0.8520287275314331 |
| keywords[0].display_name | Blockade |
| keywords[1].id | https://openalex.org/keywords/nasopharyngeal-carcinoma |
| keywords[1].score | 0.8016366958618164 |
| keywords[1].display_name | Nasopharyngeal carcinoma |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.6875714063644409 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/immunotherapy |
| keywords[3].score | 0.6744740009307861 |
| keywords[3].display_name | Immunotherapy |
| keywords[4].id | https://openalex.org/keywords/oncology |
| keywords[4].score | 0.4999220371246338 |
| keywords[4].display_name | Oncology |
| keywords[5].id | https://openalex.org/keywords/internal-medicine |
| keywords[5].score | 0.4956141710281372 |
| keywords[5].display_name | Internal medicine |
| keywords[6].id | https://openalex.org/keywords/immune-checkpoint |
| keywords[6].score | 0.4378805458545685 |
| keywords[6].display_name | Immune checkpoint |
| keywords[7].id | https://openalex.org/keywords/radiation-therapy |
| keywords[7].score | 0.1585245132446289 |
| keywords[7].display_name | Radiation therapy |
| keywords[8].id | https://openalex.org/keywords/receptor |
| keywords[8].score | 0.14489108324050903 |
| keywords[8].display_name | Receptor |
| keywords[9].id | https://openalex.org/keywords/cancer |
| keywords[9].score | 0.11241203546524048 |
| keywords[9].display_name | Cancer |
| language | en |
| locations[0].id | doi:10.1016/j.iotech.2024.100782 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S4210240197 |
| locations[0].source.issn | 2590-0188 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2590-0188 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Immuno-Oncology Technology |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Immuno-Oncology and Technology |
| locations[0].landing_page_url | https://doi.org/10.1016/j.iotech.2024.100782 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5115592874 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Chongyang Xu |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | C. Xu |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5065922439 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-4475-0260 |
| authorships[1].author.display_name | Yanghong Xia |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Y. Xia |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5115602041 |
| authorships[2].author.orcid | https://orcid.org/0000-0002-1813-7529 |
| authorships[2].author.display_name | Shi Wang |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | S. Wang |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5101683561 |
| authorships[3].author.orcid | https://orcid.org/0000-0003-1854-8827 |
| authorships[3].author.display_name | Lili Guo |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | L. Guo |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5101922058 |
| authorships[4].author.orcid | https://orcid.org/0000-0003-2392-3353 |
| authorships[4].author.display_name | Lin Shen |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | L. Shen |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5046994582 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | W-H. Hu |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | W-H. Hu |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5047670450 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-6754-3910 |
| authorships[6].author.display_name | Pu‐Yun OuYang |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | P-Y. Ouyang |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5101869643 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-1511-1841 |
| authorships[7].author.display_name | Xiaojie Fang |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | X-J. Fang |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5112911809 |
| authorships[8].author.orcid | |
| authorships[8].author.display_name | Min Nie |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | M. Nie |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5100405296 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-1137-9349 |
| authorships[9].author.display_name | Jun Ma |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | J. Ma |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5053257077 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3055-666X |
| authorships[10].author.display_name | Qiang Cai |
| authorships[10].author_position | last |
| authorships[10].raw_author_name | Q. Cai |
| authorships[10].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/j.iotech.2024.100782 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | 153P Combination of Tim-3 blockade TQB2618 with PD-1 blockade for patients with immunotherapy-resistant recurrent/metastatic nasopharyngeal carcinoma (R/M NPC): Preliminary results from a phase II study |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12505 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9983999729156494 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2730 |
| primary_topic.subfield.display_name | Oncology |
| primary_topic.display_name | Peptidase Inhibition and Analysis |
| related_works | https://openalex.org/W4393219064, https://openalex.org/W3171040582, https://openalex.org/W2263980547, https://openalex.org/W2085972006, https://openalex.org/W4361271945, https://openalex.org/W3197188017, https://openalex.org/W4200507838, https://openalex.org/W3166800855, https://openalex.org/W4362515066, https://openalex.org/W4362158722 |
| cited_by_count | 1 |
| counts_by_year[0].year | 2025 |
| counts_by_year[0].cited_by_count | 1 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/j.iotech.2024.100782 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S4210240197 |
| best_oa_location.source.issn | 2590-0188 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2590-0188 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Immuno-Oncology Technology |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Immuno-Oncology and Technology |
| best_oa_location.landing_page_url | https://doi.org/10.1016/j.iotech.2024.100782 |
| primary_location.id | doi:10.1016/j.iotech.2024.100782 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S4210240197 |
| primary_location.source.issn | 2590-0188 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2590-0188 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Immuno-Oncology Technology |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Immuno-Oncology and Technology |
| primary_location.landing_page_url | https://doi.org/10.1016/j.iotech.2024.100782 |
| publication_date | 2024-12-01 |
| publication_year | 2024 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year.max | 95 |
| cited_by_percentile_year.min | 91 |
| countries_distinct_count | 0 |
| institutions_distinct_count | 11 |
| sustainable_development_goals[0].id | https://metadata.un.org/sdg/3 |
| sustainable_development_goals[0].score | 0.7400000095367432 |
| sustainable_development_goals[0].display_name | Good health and well-being |
| citation_normalized_percentile.value | 0.71201483 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |